June 23, 2020 / 4:07 PM / 19 days ago

BRIEF-Purdue Pharma To Fund Harm Reduction Therapeutics' Development Of OTC Opioid Overdose Reversal Medication

June 23 (Reuters) - PURDUE PHARMA L.P. :

* PURDUE PHARMA L.P. TO FUND HARM REDUCTION THERAPEUTICS, INC.’S DEVELOPMENT OF OVER-THE-COUNTER OPIOID OVERDOSE REVERSAL MEDICATION

* PURDUE PHARMA - TO PROVIDE UP TO $6.5 MILLION OF ADDITIONAL FINANCIAL SUPPORT TO HRT TO ADVANCE DEVELOPMENT OF LOW-COST, OTC NALOXONE NASAL SPRAY IN U.S. Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below